A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, including hospitalizations and deaths, compared to their U.S.-made counterparts. Researchers uncovered this by matching drugs to their specific manufacturing plants, something the FDA does not disclose. The study found a shocking 54% higher risk [...]from SciTechDaily https://ift.tt/fZ09aYN
